Eve Pincus
Welcome to my fundraising page! I’m participating in Cycle for Survival to raise money for rare cancer research at Memorial Sloan Kettering Cancer Center (MSK). Will you donate and help me make a difference?
Rare cancer research is significantly underfunded. As MSK’s official rare cancer fundraiser, Cycle for Survival helps fill the gap. Since 2007, this community has enabled hundreds of doctors and scientists at MSK to pursue bold ideas that continue to transform how rare cancers are diagnosed and treated.
Your tax-deductible gift can give people with rare cancer a better future.
50% of People With Cancer Have a Rare Cancer
About half of all people with cancer have a rare form of the disease. Rare cancers include many types you’ve likely heard of, such as leukemia and lymphoma; thyroid, ovarian, brain, and pancreatic cancers; and all pediatric cancers.
100% of Your Donation Supports Research
Every dollar you give will go directly into MSK labs, where researchers have expertise in more than 400 types of cancer. Funding from Cycle for Survival has led to the FDA approval of new drugs, lifesaving clinical trials, and state-of-the-art DNA sequencers.
Real Impact, Real Fast
Your donation will be allocated within six months after fundraising ends. Not only does Cycle for Survival fund critical research but it also makes sure that donated dollars get into the hands of MSK experts as quickly as possible.
Thank you for your generosity!
Goal
The Cycle for Survival Web page and e-mail are provided as a courtesy to participants to help them manage fundraising efforts for this event. Memorial Sloan Kettering Cancer Center or any of its affiliated organizations, or their officers, directors, agents, or employees do not control, nor are they responsible for, the contents of this Web page. Any views or information provided on this Web page are the sole responsibility of the participant. The participant's Web page may provide links to other Web sites and does not imply an endorsement by MSKCC, its affiliated organizations, their officers, directors, agents, and employees of the materials contained at those Web sites. |